107 related articles for article (PubMed ID: 3981419)
1. Factors affecting the measurement of lidocaine protein binding by equilibrium dialysis in human serum.
Ponganis KV; Stanski DR
J Pharm Sci; 1985 Jan; 74(1):57-60. PubMed ID: 3981419
[TBL] [Abstract][Full Text] [Related]
2. pH lability in serum during equilibrium dialysis.
Brørs O; Jacobsen S
Br J Clin Pharmacol; 1985 Jul; 20(1):85-8. PubMed ID: 4027141
[TBL] [Abstract][Full Text] [Related]
3. [Serum protein binding of fentanyl. The effect of postoperative acute phase reaction with elevated alpha 1-acid glycoprotein and methodologic problems in determination by equilibrium dialysis].
Wiesner G; Taeger K; Peter K
Anaesthesist; 1996 Apr; 45(4):323-9. PubMed ID: 8702049
[TBL] [Abstract][Full Text] [Related]
4. Equilibrium dialysis for determination of protein binding or imipramine--evaluation of a method.
Kristensen CB; Gram LF
Acta Pharmacol Toxicol (Copenh); 1982 Feb; 50(2):130-6. PubMed ID: 7072503
[TBL] [Abstract][Full Text] [Related]
5. Binding of theophylline in human serum determined by ultrafiltration and equilibrium dialysis.
Brørs O; Sager G; Sandnes D; Jacobsen S
Br J Clin Pharmacol; 1983 Apr; 15(4):393-7. PubMed ID: 6849773
[TBL] [Abstract][Full Text] [Related]
6. Valproic acid binding to human serum albumin and human plasma: effects of pH variation and buffer composition in equilibrium dialysis.
Albani F; Riva R; Contin M; Baruzzi A
Ther Drug Monit; 1984; 6(1):31-3. PubMed ID: 6424277
[TBL] [Abstract][Full Text] [Related]
7. Factors influencing the protein binding of bumetanide using an equilibrium dialysis technique.
Shim HJ; Lee MG; Lee MH
J Clin Pharm Ther; 1991 Dec; 16(6):467-76. PubMed ID: 1770075
[TBL] [Abstract][Full Text] [Related]
8. Propranolol binding in serum: comparison of methods and investigation of effects of drug concentration, pH, and temperature.
Paxton JW; Calder RL
J Pharmacol Methods; 1983 Aug; 10(1):1-11. PubMed ID: 6632919
[TBL] [Abstract][Full Text] [Related]
9. Impact of pH on plasma protein binding in equilibrium dialysis.
Kochansky CJ; McMasters DR; Lu P; Koeplinger KA; Kerr HH; Shou M; Korzekwa KR
Mol Pharm; 2008; 5(3):438-48. PubMed ID: 18345638
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing theophylline serum protein binding.
Shaw LM; Fields L; Mayock R
Clin Pharmacol Ther; 1982 Oct; 32(4):490-6. PubMed ID: 7116764
[TBL] [Abstract][Full Text] [Related]
11. Fluid shifts and other factors affecting plasma protein binding of prednisolone by equilibrium dialysis.
Boudinot FD; Jusko WJ
J Pharm Sci; 1984 Jun; 73(6):774-80. PubMed ID: 6204037
[TBL] [Abstract][Full Text] [Related]
12. Control and measurement of plasma pH in equilibrium dialysis: influence on drug plasma protein binding.
Curran RE; Claxton CR; Hutchison L; Harradine PJ; Martin IJ; Littlewood P
Drug Metab Dispos; 2011 Mar; 39(3):551-7. PubMed ID: 21098647
[TBL] [Abstract][Full Text] [Related]
13. Measurement of lidocaine free concentration.
Beach CL; Ludden TM; Clementi WA; Allerheiligen SR
Ther Drug Monit; 1986; 8(3):326-30. PubMed ID: 3529515
[TBL] [Abstract][Full Text] [Related]
14. Methodologic factors influencing plasma binding of alpha-1-acid glycoprotein-bound and albumin-bound drugs.
Morse DS; Abernethy DR; Greenblatt DJ
Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):535-9. PubMed ID: 3934087
[TBL] [Abstract][Full Text] [Related]
15. Protein binding of lidocaine in canine serum and plasma: effects of an acidic pH and the technique of study.
Coyle DE; Denson DD
Biopharm Drug Dispos; 1984; 5(4):399-404. PubMed ID: 6525445
[No Abstract] [Full Text] [Related]
16. Factors influencing the apparent protein binding of quinidine.
Guentert TW; Oie S
J Pharm Sci; 1982 Mar; 71(3):325-8. PubMed ID: 7069591
[TBL] [Abstract][Full Text] [Related]
17. Factors influencing the protein binding of vancomycin.
Shin WG; Lee MG; Lee MH; Kim ND
Biopharm Drug Dispos; 1991 Dec; 12(9):637-46. PubMed ID: 1790309
[TBL] [Abstract][Full Text] [Related]
18. Pethidine binding in plasma: effects of methodological variables.
La Rosa C; Mather LE; Morgan DJ
Br J Clin Pharmacol; 1984 Apr; 17(4):411-5. PubMed ID: 6721987
[TBL] [Abstract][Full Text] [Related]
19. Factors influencing the protein binding of YH-439 using an equilibrium dialysis technique. A new hepatoprotective agent.
Lee WI; Yoon WH; Park JH; Lee JW; Shim CK; Lee MG
Biopharm Drug Dispos; 1995 Dec; 16(9):775-89. PubMed ID: 8580401
[TBL] [Abstract][Full Text] [Related]
20. On the modulating effects of temperature, albumin, pH and calcium on the free fractions of phenobarbitone and phenytoin.
Melten JW; Wittebrood AJ; Wemer J; Faber DB
J Pharm Pharmacol; 1986 Sep; 38(9):643-6. PubMed ID: 2877062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
